EN DE
Watch Petco Health and Wellness Company Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Petco Health and Wellness Company Inc (WOOF) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Petco Health and Wellness Company Inc stock $2.48, price $2.96, that is 16.2% below the price, quality 45 out of 100. Rating: overvalued. Calculated from audited financials with 18 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Cyclical US

PH Petco Health and Wellness Company Inc logo Some data Nov 7, 2026

Petco Health and Wellness Company Inc

WOOF · US
Expensive, weak quality

Our calculation puts a fair price 16% below what the stock costs today.

Generates free cash flow
Profit last quarter +160% vs. a year ago.
Quality 45/100
Mixed Growth (revenue 5y +3.9 %/yr in USD)
Thin margins · 0.5% net margin (TTM)
Moderate debt
Insiders sold $1.1M (6M)
Some data
Fair value $2.48 · Overvalued
Trails peers (3/12)
Narrow moat 20/100
Watch Petco Health and Wellness Company Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$25.69 $1.50 Fair Value $2.48 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

60‑month range $1.50 – $25.69 · fair‑value band $2.29 – $2.82 · the $2.96 price screens above the $2.48 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 7, 2026.

Follow Petco Health and Wellness Company in your weekly email

Every Wednesday you see whether Petco Health and Wellness Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Petco Health and Wellness Company, Inc., operates as a pet specialty retailer, focuses on enhancing the lives of pets, pet parents, and its Petco partners in the United States, Mexico, Puerto Rico, and Chile.

Show moreShow less

The company provides veterinary care, grooming, and training services; and pet care supplies and companion animals. It also offers a range of consumables, supplies, and services through its petco.com website and mobile app.

In addition, the company treats whole pet, including their physical, mental, and social well-being. It offers its products under the WholeHearted, Reddy, So Phresh, and Well & Good brand names. Petco Health and Wellness Company, Inc. was founded in 1965 and is headquartered in San Diego, California.

Stock analysis

Petco Health and Wellness Company Inc (WOOF) currently trades at $2.96, while our model-based Fair Value estimate is $2.48, 16% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of $6.78 per share, and 9 of the 17 models we run sit above the $2.96 price.

Bear case: the Earnings-Based group reads lowest at $0.2900, and 8 of the 17 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $2.29 (bear) to $2.82 (bull), the price of $2.96 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 45/100 (below-average quality), in the Consumer Cyclical sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Petco Health and Wellness Company Inc reported revenue of $6.0B in FY2026 versus $5.8B in FY2022, a compound +0.7%/yr. Reported net income was $9.1M in FY2026, compounding −51.5%/yr from FY2022.

Key figures

Market cap $860M Small · P/E ratio 24.9 · P/S ratio 0.14 · EPS (TTM) $0.1000 · Net margin 0.5% · Return on equity 2.6% · Return on assets (EBIT) −2.4% (5-year average) · Operating margin 3.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 20 out of 100 (medium confidence).

What moves the price

The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat.

The share trades about 18% below its 52-week high and 36% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Cyclical peers we cover trades at −5% fair-value upside, at −16%, WOOF screens richer than that median.

Fair Value models

Bear $2.29 Fair Value $2.48 Bull $2.82
Price $2.96 · Downside -16.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 9 months old). Earnings retained since then ($0.0773 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $5.23 $9.54 $15.05 78
Growth DCF $5.18 $8.83 $13.16 77
5Y EBITDA Exit $5.21 $11.01 $17.78 73
All 18 models by family
DCF Models
FCF DCF $5.23 $9.54 $15.05 78
5Y Revenue Exit $1.85 $4.58 $7.90 69
5Y EBITDA Exit $5.21 $11.01 $17.78 73
5Y P/E Exit n/a $0.6500 $1.42 68
10Y Revenue Exit $3.15 $5.81 $9.18 65
10Y EBITDA Exit $5.07 $9.61 $15.65 66
10Y P/E Exit $2.14 $3.49 $4.94 63
Earnings-Based
Graham-Dodd $0.2500 $0.8600 $1.16 64
Lynch FV $0.2000 $0.2900 $0.3700 61
PEG = 1.0 $0.2000 $0.2900 $0.3700 57
Multiples
P/E Multiple $0.6000 $0.8000 $1.00 63
P/S Multiple $0.4600 $0.6200 $0.7700 58
EV/EBIT n/a n/a $0.4300 61
EV/EBITDA $1.01 $4.83 $8.66 60
Growth DCF
Growth DCF $5.18 $8.83 $13.16 77
Rev-Margin DCF $1.85 $4.72 $8.19 69
Economic Profit
Residual Income $2.29 $2.48 $2.82 71
Growth Earnings
Growth-Adj P/E $0.5200 $0.7400 $0.9600 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 45/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 44
How much profit the company makes from its sales and capital
Quality Growth 49
Are margins and returns getting better?
Cashflow 49
Do the profits arrive as real cash?
Financial strength 16
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 9
How calm the share price moves, does not count
Price momentum 36
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 40
Distance to the 52-week high, does not count
New shares 35
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director sold shares worth $1.1M and none bought.

  • SaleHolly MayChief Human Resources Officer2× since Jul 7, 2026: 450,000 shares, avg. $2.55$1.1MJul 9, 2026
  • SalePatrick J VeneziaChief Revenue Officer2× since Dec 1, 2025: 176,221 shares, avg. $3.28$577,451Mar 13, 2026

Plus 12 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 47/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−2.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.9%
Start year 2021 (pandemic). Over 10 years: +10.8% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.0%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
−41.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−41.8%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−45.0% vs −35.8%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 2%
Pace: the 5-year rate starts in 2021 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes about as much growth as the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+5.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+1.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +3.1% a year for the price and −1.2% for the forecasts.
Forecast 2027 (sales)+0.5%
Forecast 2028 (sales)+1.2%
Projected 2029 (sales)+1.3%
Projected 2030 (sales)+1.4%
Projected 2031 (sales)+1.5%

WOOF screens overvalued: fair value 16% below the price. Compare with Alimentation Couche-Tard Inc →

Compare Petco Health and Wellness Company Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Retail · 203 stocks

Beats the industry median on 3/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 45 · Bottom 25%
Fair Value upside −16.2% · Below median
Profitability
Return on equity (12 months) 2.6% · Below median
Return on assets 0.2% · Bottom 25%
Net margin (12 months) 0.5% · Below median
Operating margin (12 months) 3.2% · Below median
Growth and dividend
Revenue growth (quarter YoY) 0.0% · Below median
Balance sheet
Debt / equity 1.28× · Highest 25%

Valuation Multiplesvs Specialty Retail median · lower = cheaper

P/E (12 months) 24.9× · Pricier than median
P/B 0.74× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 0.14× · Cheapest 25%
Price / free cash flow (fiscal year) 4.6× · Cheapest 25%
EV/EBITDA 6.3× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)12 · sector 50
FUTURE (revenue growth)0 · sector 25
PAST (return on equity)10 · sector 33
HEALTH (low debt)36 · sector 93
DIVIDEND (yield)0 · sector 54

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Retail stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
DICK'S Sporting Goods, Inc DKS $140.82 $201.62 +43% vs WOOF
Alimentation Couche-Tard Inc ATD C$83.20 C$106.00 +27% vs WOOF
Ulta Beauty, Inc ULTA $644.76 $650.56 +1% vs WOOF
Tractor Supply Company TSCO $36.35 $36.33 +0% vs WOOF
Best Buy Co BBY $99.63 $94.70 −5% vs WOOF
China Tourism Group 601888 ¥54.22 ¥48.19 −11% vs WOOF
Five Below, Inc FIVE $240.30 $184.99 −23% vs WOOF
Williams-Sonoma, Inc WSM $254.06 $164.11 −35% vs WOOF
Casey's General Stores, Inc CASY $687.64 $405.93 −41% vs WOOF
GameStop Corp GME $25.12 $11.87 −53% vs WOOF

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Petco Health and Wellness Company Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Petco Health and Wellness Company Inc Fair Value". https://www.fairvalue-calculator.com/stock/WOOF

Frequently asked questions

Is Petco Health and Wellness Company Inc (WOOF) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of $2.48 versus a price of $2.96, about 16% lower (overvalued).
What is the fair value of WOOF?
Our model-based fair value for Petco Health and Wellness Company Inc is $2.48 (as of Nov 7, 2026), built from audited fundamentals. The current price: $2.96.
What is the quality score of WOOF?
Petco Health and Wellness Company Inc has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Petco Health and Wellness Company Inc (WOOF)?
Our model-based price target is the fair value of $2.48 (as of Nov 7, 2026) from 18 valuation models. Cautious scenario $2.29, optimistic scenario $2.82. It is a calculation from audited fundamentals, not an analyst target.
What is the Petco Health and Wellness Company Inc stock forecast for 2026?
Our models put fair value at $2.48, about 16% lower versus a price of $2.96 (overvalued). Cautious scenario $2.29, optimistic scenario $2.82. The calculation is refreshed regularly with new filings.
What is the revenue of Petco Health and Wellness Company Inc (WOOF)?
Petco Health and Wellness Company Inc reported trailing-twelve-month revenue of about $6.0B (latest available figure, as of Nov 7, 2026).
What growth is priced into Petco Health and Wellness Company Inc (WOOF)?
For today's price to be fair in a discounted-cash-flow model, Petco Health and Wellness Company Inc would have to grow free cash flow by +5.6 % per year for five years (discount rate 12.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.9 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of WOOF use?
Our models discount Petco Health and Wellness Company Inc at 12.9 %: a base by market capitalisation (small), damped by beta 1.59, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Petco Health and Wellness Company Inc that is +5.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.9 %) and the same formula as our fair value.
How much growth has Petco Health and Wellness Company Inc (WOOF) delivered so far?
Over the past 5 years revenue at Petco Health and Wellness Company Inc grew +3.9 % a year. The price currently implies free-cash-flow growth of +5.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Petco Health and Wellness Company Inc (WOOF) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Petco Health and Wellness Company Inc (+5.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Petco Health and Wellness Company Inc (WOOF)?
The free-cash-flow yield on the price is 21.74 %: that much free cash flow Petco Health and Wellness Company Inc produces per unit of market value. When it exceeds the discount rate of our models (12.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Petco Health and Wellness Company Inc (WOOF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Petco Health and Wellness Company Inc it is $2.48 per share (as of Nov 7, 2026), against a price of $2.96. It is the blended result of 18 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Growth DCF, Economic Profit, Growth Earnings).
Is Petco Health and Wellness Company Inc stock overvalued or undervalued in 2026?
As of Nov 7, 2026, WOOF trades above its calculated fair value: price $2.96, fair value $2.48, a gap of about −16% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of WOOF?
No. The price is what the market pays today ($2.96); the fair value is what the company's own numbers justify ($2.48). For Petco Health and Wellness Company Inc the two are $0.4800 per share apart. That gap is exactly why we show both numbers side by side.
How much is Petco Health and Wellness Company Inc worth?
The market values Petco Health and Wellness Company Inc at about $860M (market capitalisation, as of Nov 7, 2026). Per share that is $2.96; our models calculate a fair value of $2.48 per share.
What do the bullish and bearish scenarios say about WOOF?
Our models span a range for Petco Health and Wellness Company Inc: cautious scenario $2.29, base $2.48, optimistic $2.82 per share (as of Nov 7, 2026, price $2.96). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of WOOF?
Petco Health and Wellness Company Inc trades at a price-to-earnings ratio of 24.9 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $2.48 is built from several models across several years. Excluding one-off items of fiscal year 2026 it is 59.2 (reported for FY2026: 98.7). Other multiples: P/B 0.7, P/S 0.1, EV/EBITDA 6.3.
How solid is the balance sheet of Petco Health and Wellness Company Inc (WOOF)?
Balance-sheet figures for Petco Health and Wellness Company Inc (as of Nov 7, 2026): return on equity 2.6%, debt of 1.28 per unit of equity. They feed the Quality Score of 45/100, which measures business quality independently of the share price.
How far is WOOF from its 52-week high?
Petco Health and Wellness Company Inc trades at $2.96, about 18% below its 52-week high of $3.62 and 36% above the low of $2.18 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $2.48 is for.
Which stocks are comparable to Petco Health and Wellness Company Inc?
From the same area (Consumer Cyclical) we also value Alimentation Couche-Tard Inc, Williams-Sonoma, Inc, Ulta Beauty, Inc, Casey's General Stores, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Petco Health and Wellness Company Inc stock attractive at the current price?
The data as of Nov 7, 2026: price $2.96, calculated fair value $2.48 (−16%), Quality Score 45/100, from 18 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of WOOF calculated?
We run Petco Health and Wellness Company Inc through 18 models from 6 families: DCF Models, Earnings-Based, Multiples, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $2.48 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Petco Health and Wellness Company Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Petco Health and Wellness Company Inc (WOOF)?
The closing price on Nov 6, 2026 was $2.96. Our model-based fair value is $2.48, about 16% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Petco Health and Wellness Company Inc right now?
The price sits above even our optimistic bull case ($2.82). The favourable scenario is already priced in. Weak quality (45/100) and above fair value at the same time, the margin of safety is missing on both counts.

Key figures of Petco Health and Wellness Company Inc

How large is the market capitalisation of Petco Health and Wellness Company Inc (WOOF)?
The market capitalisation of Petco Health and Wellness Company Inc is $860M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Petco Health and Wellness Company Inc (WOOF)?
The price-to-sales ratio of Petco Health and Wellness Company Inc is 0.14 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Petco Health and Wellness Company Inc (WOOF)?
Earnings per share at Petco Health and Wellness Company Inc are $0.1000 (price ÷ EPS = P/E 24.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Petco Health and Wellness Company Inc (WOOF)?
The net margin of Petco Health and Wellness Company Inc is 0.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Petco Health and Wellness Company Inc (WOOF)?
The return on equity (ROE) of Petco Health and Wellness Company Inc is 2.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Petco Health and Wellness Company Inc (WOOF)?
On an EBIT basis the return on assets of Petco Health and Wellness Company Inc is −2.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Petco Health and Wellness Company Inc (WOOF)?
The operating margin of Petco Health and Wellness Company Inc is 3.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast are earnings growing at Petco Health and Wellness Company Inc (WOOF)?
Earnings per share at Petco Health and Wellness Company Inc are growing +160% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Petco Health and Wellness Company Inc (WOOF) carry?
The net debt of Petco Health and Wellness Company Inc is $2.6B (fiscal year 2026, ≈ 13.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Petco Health and Wellness Company Inc in the live analysis

One click puts Petco Health and Wellness Company Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.